About Lamed
Lamed is a company based in Oberhaching (Germany) founded in 1989 by Lazaros Ayvatoglou was acquired by Translumina in June 2023.. Lamed offers products and services including Ankura TAA Stent Graft System, Vascu-Guard, Fustar Steuerbare Schleuse, and H.Q.S Schleuse. Lamed operates in a competitive market with competitors including TISSIUM, Aziyo Biologics, Cardival Medical, Laminate Medical and Vivasure Medical, among others.
- Headquarter Oberhaching, Germany
- Founders Lazaros Ayvatoglou
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Translumina
(Jun 07, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lamed
Lamed offers a comprehensive portfolio of products and services, including Ankura TAA Stent Graft System, Vascu-Guard, Fustar Steuerbare Schleuse, and H.Q.S Schleuse. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for treating thoracic aortic dissections and aneurysms via endovascular methods.
Acellular patch used in vascular surgery for tissue reinforcement.
Steerable sheath for precise occluder placement in procedures.
Introduction sheath optimized for endovascular access in surgeries.
Funding Insights of Lamed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lamed
Lamed has secured backing from 1 investor. Prominent investors backing the company include Translumina. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of drug-eluting stents and cardiovascular devices. It produces drug-eluting stents, drug-eluting balloons, coronary balloons, and vascular accessories. The company operates advanced manufacturing facilities and is committed to delivering high-quality products. Its focus is on developing and providing innovative cardiovascular intervention technologies. The manufacturing processes adhere to rigorous international standards.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lamed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lamed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lamed Comparisons
Competitors of Lamed
Lamed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Aziyo Biologics, Cardival Medical, Laminate Medical and Vivasure Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| domain | founded_year | HQ Location |
A device for vascular access management is developed.
|
|
| domain | founded_year | HQ Location |
AV fistula maturation and patency are supported by VasQ device.
|
|
| domain | founded_year | HQ Location |
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
|
| domain | founded_year | HQ Location |
Ultrasound thrombolytic devices for pulmonary embolism treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Lamed
When was Lamed founded?
Lamed was founded in 1989.
Where is Lamed located?
Lamed is headquartered in Oberhaching, Germany. It is registered at Oberhaching, Bavaria, Germany.
What does Lamed do?
The company was founded in 1989 and is based in Oberhaching, Germany. Endovascular solutions are developed for thoracic aortic dissections, aneurysms, and related conditions. Products such as the Ankura TAA stent graft system and the Peri-guard repair patch are included in the portfolio. Operations focus on medical device innovation within the cardiovascular sector, with distribution across Europe.
Who are the top competitors of Lamed?
Lamed's top competitors include TISSIUM, Vivasure Medical and Cardival Medical.
What products or services does Lamed offer?
Lamed offers Ankura TAA Stent Graft System, Vascu-Guard, Fustar Steuerbare Schleuse, and H.Q.S Schleuse.
Who are Lamed's investors?
Lamed has 1 investor. Key investors include Translumina.